Indoxyl sulfate: clinical implications for anemia management in chronic kidney disease

By afschroeder • December 8, 2025

Rattanasompattikul M, Srithongkul T, Tantisattamo E, Kalantar-Zadeh K, Noppakun K. Indoxyl sulfate: clinical implications for anemia management in chronic kidney disease. Curr Opin Nephrol Hypertens. 2025 Dec 8. doi: 10.1097/MNH.0000000000001145. Epub ahead of print. PMID: 41355384.

Tags: dialysis modalities, erythropoiesis, gut microbiota, Harbor UCLA, iron metabolism, Nephrology, Publications, uremic toxins

Low Prevalence of Coronary Artery Calcium in High Cardiometabolic Risk Kenyan Adults with and Without HIV: The ASANTE Study

Shah H, Krishnan S, Narashim A, Korir S, Omondi G, Maxime Ale B, Gitura BM, Kinuthia J, Farquhar C, Hsue PY, Budoff M, Longenecker CT,[...]

Sex and reproductive stage modify the effect of endogenous oestrogens on coronary atherosclerosis in rheumatoid arthritis

Karpouzas GA, Papotti B, Ormseth SR, Palumbo M, Hernandez E, Budoff MJ, Ronda N. Sex and reproductive stage modify the effect of endogenous oestrogens on[...]

Efficacy assessments of EL219, a next-generation polyene antifungal, in immunosuppressed mice infected with drug-sensitive and drug-resistant Aspergillus isolates

Youssef EG, Gebremariam T, Gu Y, Patterson H, Alkhazraji S, Elsayed T, Wiederhold NP, Ibrahim AS. Efficacy assessments of EL219, a next-generation polyene antifungal, in[...]